Signaling pathways and targeted therapies for psoriasis.
Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. · 2023
Read Signaling pathways and targeted therapies for psoriasis. by Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10679229.txt.
Introduction
Guo and co-authors reviewed psoriasis in 2023, a chronic skin disease driven by immune faults. Scales and red patches mark the skin, and the burden on patients and health systems runs high. New drugs have changed care in the past years. Rarer forms of the disease are still poorly grasped.
The review maps signals that pass between cells and inside them, Guo reports. It also weighs fuel use and gene control shifts that may drive the disease. Links to other ills, such as joint and heart disease, get a close look. Two flaws of current care stand out: harsh side effects and return of disease when drugs stop. Targeted drugs and fresh plans fill the last part.
Catalog record
| CREATOR | Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 247 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |